Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Dextroamphetamine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dextroamphetamine sulfate and what is the scope of dextroamphetamine sulfate patent protection?

Dextroamphetamine sulfate
is the generic ingredient in five branded drugs marketed by Actavis Elizabeth, Ferndale Labs, Glaxosmithkline, Lannett, Able, Mast Mm, Purepac Pharm, Halsey, Novel Labs Inc, Mikart, Mylan Pharms Inc, Teva, Mallinckrodt, Mayne Pharma, Tris Pharma Inc, Avanthi Inc, Shire, Corepharma, Barr, Nesher Pharms, Idt Australia Ltd, Sandoz, Outlook Pharms, Amedra Pharms, Vitarine, Aurolife Pharma Llc, and Vintage Pharms Llc, and is included in thirty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for dextroamphetamine sulfate. Twenty-five suppliers are listed for this compound.

Summary for Generic Name: dextroamphetamine sulfate

Drug Master File Entries: see list17
Suppliers / Packagers: see list25
Clinical Trials: see list280
Therapeutic Class:Central Nervous System Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dextroamphetamine sulfate at DailyMed

Pharmacology for Ingredient: dextroamphetamine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL206735-001Jan 27, 2016ABRXNoNo► Subscribe► Subscribe
Mayne Pharma
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL076137-003Jan 18, 2002ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
dextroamphetamine sulfate
CAPSULE, EXTENDED RELEASE;ORAL206735-002Jan 27, 2016ABRXNoNo► Subscribe► Subscribe
dextroamphetamine sulfate
TABLET;ORAL085892-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
dextroamphetamine sulfate
TABLET;ORAL040436-002Jan 29, 2002AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus